Full text
PDFPage 876
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baak J. P., Van Dop H., Kurver P. H., Hermans J. The value of morphometry to classic prognosticators in breast cancer. Cancer. 1985 Jul 15;56(2):374–382. doi: 10.1002/1097-0142(19850715)56:2<374::aid-cncr2820560229>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
- Baak J. P., van Diest P. J., Ariens A. T., van Beek M. W., Bellot S. M., Fijnheer J., van Gorp L. H., Kwee W. S., Los J., Peterse H. C. The Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in The Netherlands. Pathol Res Pract. 1989 Nov;185(5):664–670. doi: 10.1016/S0344-0338(89)80213-4. [DOI] [PubMed] [Google Scholar]
- Meyer J. S., Bauer W. C., Rao B. R. Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content. Lab Invest. 1978 Sep;39(3):225–235. [PubMed] [Google Scholar]
- Silvestrini R., Daidone M. G., Gasparini G. Cell kinetics as a prognostic marker in node-negative breast cancer. Cancer. 1985 Oct 15;56(8):1982–1987. doi: 10.1002/1097-0142(19851015)56:8<1982::aid-cncr2820560816>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
- Tosi P., Luzi P., Sforza V., Santopietro R., Bindi M., Tucci E., Barbini P., Baak J. P. Correlation between morphometrical parameters and disease-free survival in ductal breast cancer treated only by surgery. Appl Pathol. 1986;4(1-2):33–42. [PubMed] [Google Scholar]
- Uyterlinde A. M., Baak J. P., Schipper N. W., Peterse H., Matze E., Meijer C. J. Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up. Int J Cancer. 1990 Jan 15;45(1):1–7. doi: 10.1002/ijc.2910450102. [DOI] [PubMed] [Google Scholar]
- van Diest P. J., Baak J. P. The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients. Hum Pathol. 1991 Apr;22(4):326–330. doi: 10.1016/0046-8177(91)90080-9. [DOI] [PubMed] [Google Scholar]
- van der Linden J. C., Baak J. P., Lindeman J., Hermans J., Meyer C. J. Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer. J Clin Pathol. 1987 Mar;40(3):302–306. doi: 10.1136/jcp.40.3.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van der Linden J. C., Lindeman J., Baak J. P., Meijer C. J., Herman C. J. The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients. Cytometry. 1989 Jan;10(1):56–61. doi: 10.1002/cyto.990100110. [DOI] [PubMed] [Google Scholar]